Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis

SIMPLE SUMMARY: Neoadjuvant fluoropyrimidine (5FU or capecitabine)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Our Meta-analysis showed that the combining oxaliplatin with capecitabine or 5FU in preoperative chemoradiotherapy or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Des Guetz, Gaëtan, Landre, Thierry, Bollet, Marc A., Mathonnet, Muriel, Quéro, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657124/
https://www.ncbi.nlm.nih.gov/pubmed/34885147
http://dx.doi.org/10.3390/cancers13236035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657124/
https://www.ncbi.nlm.nih.gov/pubmed/34885147
http://dx.doi.org/10.3390/cancers13236035

Ejemplares similares